Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

NCT05361707 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Autism Spectrum Disorder
Sleep Disorder
Neurological Disorder
Sleep Disturbance

Interventions

DRUG: Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension

Sponsor

Vanda Pharmaceuticals